6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	SFG Quarterly Activities/Appendix 4CCash Flow Report
Just now	BSA Announces On-Market Share Buy-Back
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C

About

Moonlake Immunotherapeutics (NASDAQ:MLTX) — investor relations, events, news, and company updates on 6ix.

Latest News

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

Financials

Revenue

$0

Market Cap

$1.22 B

EPS

-3.53

Community Chat

Ask AI